Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.

Expert opinion on drug metabolism & toxicology - 1 Aug 2011

Sai Kimie, Saito Yoshiro

Abstract excerpt

INTRODUCTION: Large inter-individual and inter-ethnic differences are observed in efficacies and toxicities of medical drugs. To improve the predictability of these differences, pharmacogenetic information has been applied to clinical situations. Expanding pharmacogenetic information would be a valuable tool to the medical community as well as the patient to fulfill the promise of personalized anticancer drug...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Hormonal
Share to Antineoplastic Agents, Phytogenic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Camptothecin

Share to Deoxycytidine

Share to Gemcitabine

Share to Irinotecan

Share to Multidrug Resistance-Associated Protein 2

Share to Tamoxifen

Source

Identifiers

PMID: 21585235
DOI: 10.1517/17425255.2011.585969

Genes

ABCB1
ABCC2
ABCG2
CDA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.PMID 21585235Read ↗

Ethnic differences in drug metabolism and toxicity from chemotherapy.Semantic proximity Read ↗

Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.Semantic proximity Read ↗

Part 2: pharmacogenetic variability in drug transport and phase I anticancer drug metabolism.Semantic proximity Read ↗

Cancer pharmacogenomics: implications on ethnic diversity and drug response.Semantic proximity Read ↗

Pharmacogenetics of Drugs Used in the Treatment of CancersSemantic proximity Read ↗

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?Semantic proximity Read ↗

Pharmacogenetics of IrinotecanSemantic proximity Read ↗

Part 3: Pharmacogenetic variability in phase II anticancer drug metabolism.Semantic proximity Read ↗

Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents.Semantic proximity Read ↗

Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Semantic proximity Read ↗

[Cancer pharmacogenetics: study of genetically determined variations on cancer susceptibility due to xenobiotic exposure].Semantic proximity Read ↗

Clinical Impact of Genetic Variants of Drug Transporters in Different Ethnic Groups within and Across RegionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.